|
KAYNAKLAR
1. Kalyoncu A. Eroin Bağımlılığı. Türkiye Klinikleri J Int Med Sci
2005;1:79-88.
2 Sherwood RA, Keating J, Kavvadia V, Greenough A, Peters TJ.
Substance misuse in early pregnancy and relationship to fetal
outcome. Eur J Pediatr 1999;158:488-492.
3. Boer K, Smit BJ, Vanhuis AM, Hogerzeil HV. Substance use in
pregnancy—do we care? Acta Paediatrica Suppl 1994;404:65-
71.
4. Hulse GK, Milne E, English DR, Holman CDJ. Assessing the
relationship between maternal opiate use and neonatal mortality.
Addiction 1998;93:1033-1042.
5. Hulse GK, Milne E, English DR, Holman CDJ. The relationship
between maternal use of heroin and methadone and infant birth
weight. Addiction 1997;92:1571-1579.
6. Behnke M, Eyler FD. The consequences of prenatal substance
use for the developing fetus, newborn and young child. Int J
Addict 1993;28:1341-1391.
7. Sinha C, Ohadike P, Carrick P, Pairaudeau P, Armstrong D,
Lindow SW. Neonatal outcome following maternal opiate use in
late pregnancy. Int J Obstet Gynaecol 2001;74:241-246.
8. Kuschel C. Managing drug withdrawal in the newborn infant.
Seminars in Fetal & Neonatal Medicine 2007;12:127-133.
9. Abdel-Latif ME, Pinner J, Clews S, Cooke F, Lui K, Oei J. Effects of
breast milk on the severity and outcome of neonatal abstinence
syndrome among infants of drug-dependent mothers. Pediatrics
2006;117:1163-1169.
10. Ostrea EM Jr. Testing for exposure to illicit drugs and other agents
in the neonate: a review of laboratory methods and the role of
meconium analysis. Curr Probl Pediatr 1999;29:37-56.
11. Lainwala S, Brown ER, Weinschenk NP, Blackwell MT, Hagadorn
JI. A retrospective study of length of hospital stay in infants
treated for neonatal abstinence syndrome with methadone versus
oral morphine preparations. Adv NeonatalCare 2005;5:265-272.
12. Okan F, Bulbul A, Nuhoglu A. Gebelikte madde suistimali. Çocuk
Dergisi 2007;7:76-80.
Dostları ilə paylaş: |
|
|